MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients - Wikidata - wikimedia - TriplyDB

MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients

MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients

http://www.wikidata.org/entity/Q41412889

about

Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways.Overexpression of miR‑145 in U87 cells reduces glioma cell malignant phenotype and promotes survival after in vivo implantation Integrated microRNA, mRNA, and protein expression profiling reveals microRNA regulatory networks in rat kidney treated with a carcinogenic dose of aristolochic acid.miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.Circulating ADAM17 Level Reflects Disease Activity in Proteinase-3 ANCA-Associated Vasculitis microRNA-451 inhibited cell proliferation, migration and invasion through regulation of MIF in renal cell carcinoma Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis.Cancer subclonal genetic architecture as a key to personalized medicine.MicroRNAs regulate human adipocyte lipolysis: effects of miR-145 are linked to TNF-α.miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathway.MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression.MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review).MicroRNA-451 regulates chemoresistance in renal cell carcinoma by targeting ATF-2 gene.MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.Demethylation-mediated miR-129-5p up-regulation inhibits malignant phenotype of osteogenic osteosarcoma by targeting Homo sapiens valosin-containing protein (VCP).A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype.MiR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17.microRNA-145 downregulates SIP1-expression but differentially regulates proliferation, migration, invasion and Wnt signaling in SW480 and SW620 cells.MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma.microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.Serum microRNA-145 as a novel biomarker in human ovarian cancer.HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors Onset and Progression of Human Osteoarthritis-Can Growth Factors, Inflammatory Cytokines, or Differential miRNA Expression Concomitantly Induce Proliferation, ECM Degradation, and Inflammation in Articular Cartilage?

P2860

Q26783563-D010D279-3EEF-47E1-9066-8D736B0F35D7 Q33694120-B09EB502-FABD-48B0-BE67-E275417850AE Q33761979-A8C44B4A-0191-4077-959E-99C2AF5D8299 Q34571491-B5630F40-9160-4551-BEC2-DFC6A0E15AD8 Q35073341-196D6237-B086-47AA-9F80-09BB7774F827 Q35624614-289379E8-2C3B-4DE7-A7B6-E794002B943C Q35781387-E9A20FFD-0398-48F1-8F64-6DD280600420 Q36059910-36762DA7-EA25-4C94-B461-3A3BADF3FF88 Q36223254-DEC316A6-DAA6-4553-8CF2-DF16D7AD6D17 Q36511669-2C03D075-EB79-43C8-98FD-E118A66F6C21 Q36544528-C9308056-5DE0-4137-A4EF-86B68C6D956D Q36939358-7A2C4CC4-27E0-4F75-9A79-1540679C3AAD Q37448116-3855E872-0BED-4C21-9DD3-2BB71835FA10 Q37514310-CD2A9838-C731-4256-8201-71AF2E7E7BBF Q37687490-099AA11E-2735-4CC4-BB83-A0A692B6B049 Q37718458-B9594857-3AD9-4EC7-9740-8D5FF7CC2D07 Q38331867-1AB2B6F9-10D2-4B78-AFCE-76DC2E600051 Q38356005-931DF620-BF00-4D95-9130-171820D18DC4 Q38706599-C1C1B9E2-52BF-4F30-8C15-85A0F475DF82 Q38738233-0AF3FC7C-6F59-4FD7-95C8-D94BAF4990D5 Q38922378-2E053AAB-B51E-45D4-83C7-B258CCB4CA69 Q39996382-A285995B-20DA-46E9-9BB1-862C001B0358 Q40004931-11BA1A16-649F-4B8D-ABB8-225BD35BF491 Q42059123-C7BBE975-EE73-46F8-9AC8-E39AB7FB4612 Q47916413-68C00204-C6D3-4B75-8AC2-7C70FBF0C8ED Q52899937-BD197AEC-1C7D-4791-90A9-204FCCF340F1 Q52946388-52FAEE95-FE02-4140-812D-2387EB96ED2B Q53602008-B2D63F90-82F0-45E4-93B4-CE86284937C5 Q57823913-515A0FC5-4616-4605-B963-61B13D0CD9EE Q58800992-648FA7D5-D9B3-4D55-9FCE-B61F39E2DB13

P2860

MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients

http://www.wikidata.org/entity/Q41412889

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

MicroRNA-145 targets the metal ...... renal cell carcinoma patients

@en

type

label

MicroRNA-145 targets the metal ...... renal cell carcinoma patients

@en

prefLabel

MicroRNA-145 targets the metal ...... renal cell carcinoma patients

@en

P1433

Q41412889-F0F2AD67-E435-49E9-BDD0-A33EB2810946

P1476

Q41412889-F9043368-69FE-420A-B679-414BC7926DED

P2093

Q41412889-2359A71D-CB64-4D49-A506-7D08F764621F

Q41412889-2E423BD2-3FC0-4842-A3F4-0BF0E64C8639

Q41412889-47BF9E68-A834-42B2-9E47-0BD55C01CC94

Q41412889-53B9348A-EBC3-4DB7-9717-E5A92D9EF615

Q41412889-8DEB67D5-3E2C-4700-AC17-3D115B26CA37

Q41412889-9004771A-D6DF-4AFC-8CA8-A6AF628F9DC7

Q41412889-9ACB0D1A-666C-4A3D-9359-A6360BABB8F9

Q41412889-B35010BE-2C9E-435B-9DF0-71E870329CE2

P2860

Q41412889-0F73FF4D-2808-4A0A-A603-29BA9CB7AB20

Q41412889-116445AB-BD05-477E-949B-30B04944BAD0

Q41412889-18AFA43D-95C0-43AD-975D-64B29AEA9EE5

Q41412889-1E275AA8-A74A-4E48-B170-4339D250CBE6

Q41412889-212B51DC-11A0-47DB-85C1-704B5666F185

Q41412889-239D0955-BC0B-4365-9BE3-558A22E7CEE5

Q41412889-244D08A3-E1AF-4AA9-8FC1-C1601105037A

Q41412889-273FA159-4524-4172-ABF2-222D699B9759

Q41412889-3CBFF45F-3FF4-458B-B98C-4F1DF207C9EC

Q41412889-3E0E1B26-9F31-42F4-9F0A-628CA5F6854B

P304

Q41412889-27BB918F-DE2A-487B-8969-D7BD8AB60A16

P31

Q41412889-9DC71B00-C4BB-40E7-9960-4333BE1040B5

P356

Q41412889-585DEE0C-A1BD-4A39-B903-4107BC59CF87

P433

Q41412889-FD0603E9-98CD-4D0C-BDC9-E547FCB942AC

P478

Q41412889-FD161A75-E97E-4AA6-B587-5B9960653900

P50

Q41412889-23128C55-8106-4628-B8D6-5E8785CF7F63

Q41412889-95D3B180-6CE3-4405-9776-32430B169904

P577

Q41412889-AD593899-4A5C-4298-8F29-23C9F602FEA2

P5875

Q41412889-E68D60B5-7DEC-4581-9F95-5FD76F6578A9

P698

Q41412889-3DDCD955-26BB-4045-8A07-541517383F62

P921

Q41412889-74083246-3A22-4C77-8115-4FFD2D29EC27

P932

Q41412889-AF2D11C2-9DEA-4702-A5B8-2F32089E58DF

P356

P1433

P1476

MicroRNA-145 targets the metal ...... renal cell carcinoma patients

@en

P2093

Ann-Kathrin Hartmetz

http://www.w3.org/2001/XMLSchema#string

Eva Juengel

http://www.w3.org/2001/XMLSchema#string

Josef Pfeilschifter

http://www.w3.org/2001/XMLSchema#string

Michel Mittelbronn

http://www.w3.org/2001/XMLSchema#string

Nico Steinmeyer

http://www.w3.org/2001/XMLSchema#string

Paul Gutwein

http://www.w3.org/2001/XMLSchema#string

Roman Blaheta

http://www.w3.org/2001/XMLSchema#string

Wolfgang Eberhardt

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-145 targets YES and STAT1 in colon cancer cells

miR-145 and miR-143 regulate smooth muscle cell fate and plasticity

MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells

Real-time quantification of microRNAs by stem-loop RT-PCR

A microRNA expression signature of human solid tumors defines cancer gene targets

The aquaporin family of molecular water channels

The functional significance of microRNA-145 in prostate cancer

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation

MicroRNA targets in Drosophila

P304

218-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.121222

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Patrick N. Harter

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235730687

http://www.w3.org/2001/XMLSchema#string

P698

23441135

http://www.w3.org/2001/XMLSchema#string

P921

P932

3579323

http://www.w3.org/2001/XMLSchema#string